ESC 365 - A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials

ESC Premium Access

A novel biomarker-based risk score to predict death in patients with atrial fibrillation: Insights from the ARISTOTLE and RE-LY trials

Session: Stroke risk prediction in atrial fibrillation

Topic: Atrial fibrillation (AF)

Speaker: Associate Professor Z. Hijazi (Uppsala, SE)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Associate Professor Ziad Hijazi

Uppsala University, Uppsala (Sweden)

4 presentations

0 follower

4 more presentations in this session

State of the Art: stroke risk prediction in atrial fibrillation

Speaker: Doctor I. Savelieva (London, GB)

Female sex is a risk modifier - not a risk factor - for stroke risk assessment in atrial fibrillation: Using a CHA2DS2-VA score rather than CHA2DS2-VASc

Speaker: Mr P. Nielsen (Aalborg, DK)

Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry

Speaker: Doctor M. Proietti (Milan, IT)

Biomarkers for stroke risk prediction in atrial fibrillation

Speaker: Professor J. Oldgren (Uppsala, SE)

Access the full session

Stroke risk prediction in atrial fibrillation

Speakers: Associate Professor Z. Hijazi, Doctor I. Savelieva, Mr P. Nielsen, Doctor M. Proietti, Professor J. Oldgren

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources